FREM2 and glioblastoma: Due to the membrane-associated localization of FREM2 and its overexpression in glioblastomas, the FREM2-specific nanobody can be used for selective targeting of glioblastoma cells with minimal damage to adjacent cells and without the need for entering the cell.